![](https://www.rollxvans.com/wp-content/uploads/2023/06/Rett-Syndrome-Trofinetide-FDA-Approval-Rollx-Vans.jpg)
In March, the Food and Drug Administration announced an important milestone in the fight against Rett syndrome. The FDA approved Daybue (trofinetide), a prescription oral treatment for adults and children 2 years of age and older who suffer from this rare but devastating neurological disorder. The development and approval of the first official treatment for Read more…